The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Anavex Life Sciences Corp. - Developing Therapeutics to Combat Alzheimer’s disease, other CNS Diseases and Various Types of Cancer

In this SNN Q&A, SNN's Robert Kraft spoke with Dr. Christopher Missling, President and CEO of Anavex Life Sciences Corp. (OTCQB: AVXL) about their progress towards developing Central Nervous System therapeutics, specifically, their lead indication for Alzheimer's disease.

Share With

Monday, September 29, 2014

   

© 2017 Stock News Now